Entero Healthcare Solutions IPO is an integrated healthcare product distribution platform that adds value to the overall healthcare ecosystem. It provides access to pharmacies, hospitals, and clinics through its 73 warehouses spread across the country. The company has supply relationships with more than 1,900 healthcare product manufacturers and offers more than 64,500 product SKUs.
Entero was established in 2018 to create a well-organized, technology-driven, and pan-Indian integrated healthcare product distributorship platform. The IPO has been structured through an offer for the sale of shares by the existing shareholders and an issue of fresh shares by the company. The company plans to use the proceeds from the IPO to repay debt, meet the long-term working capital requirements of the company and its subsidiaries, and pursue inorganic growth initiatives through acquisitions.
The IPO has been priced between Rs1,195 to Rs1,258 per equity share of the face value of Rs10. The IPO opens on Friday, February 9, and will close on Tuesday, February 13. The company has set aside a minimum of 75% for qualified institutional buyers (QIB), 15% for non-institutional institutional investors (NII) and 10% for retail investors. The company is also reserving a portion of the IPO for eligible employees, who will be entitled to get a discount of up to Rs119 per equity share.
If you are looking to invest in the upcoming IPO of Entero Healthcare Solutions, we recommend that you seek professional advice and thoroughly research the company. Please do keep in mind that the investment decision should be based on your financial situation, investment objectives, and risk tolerance. Invest only in what you can afford to lose and always diversify your portfolio.
How to Check IPO Allotment Status
The allotment status of the Entero Healthcare Solutions IPO will be declared on February 14, 2024. Applicants can track their application status by visiting the link provided below. They will be able to see whether they have been allotted shares and the quantity of shares allocated to them. Once allotment is complete, shares will be credited to the investor’s demat account and trading on the NSE and BSE will commence.
The IPO of Entero Healthcare Solutions will test the market’s appetite for HealthTech stocks in India. It is advised that interested investors carefully review the IPO prospectus and investor presentation, and consider allotment and refund dates, market conditions, regulatory landscape, and global economic trends before making any investment decision. If you are unsure, we recommend that you consult with a financial advisor.
